Page 88 - Problem-Based Feline Medicine
P. 88

80   PART 2   CAT WITH LOWER RESPIRATORY TRACT OR CARDIAC SIGNS


            supply calories from fats that are absorbed directly  and removed once the fluid production through
            into the portal circulation and bypass the thoracic  the tube falls below 1 ml/kg daily.
            duct lymphatics. Whether this truly decreases tho-  – There is current debate whether this procedure is
            racic duct flow has come under question in the   useful in idiopathic lymphangiectasia, or whether
            dog, and information is still lacking in cats. MCT  the lymphatic hypertension continues despite lig-
            oil is generally reserved for extremely cachectic  ation.
            cats. It tastes terrible, and may worsen inap-  – Pleuroperitoneal drainage, either with passive
            petance.                                         drains with diaphragmatic mesh implants, or
          ● Nutriceutical “fat binders” such as Chitin/      active sump drains between the pleural and peri-
            Chitosan may be beneficial to decrease the fat-  toneal cavities have been described, but there is
            induced chlye flow.                              a lack of data on the outcomes of these proce-
          ● Rutin, another oral nutriceutical therapy, has   dures in cats. Blockage of the drain is a problem.
            shown mixed results in idiopathic chylothorax.  – Some surgeons report success with pericardec-
          ● Rutin is a bioflavanoid and a derivative of vitamin  tomy, as a means to decrease the underlying
            C. It stimulates macrophage uptake of protein and  lymphatic hypertension. Recent studies combin-
            processing of inflammatory cells, thus improving  ing pericardectomy with thoracic duct ligation
            the absorption of the remaining fluid. Dose is 50  have resulted in 80% success in a group of ten
            mg/kg tin, which can be mixed up with food.      cats with chylothorax.
          ● Octreotide (Sandostatin, Novartis) a synthetic
            somatostatin is being trialled in cats as a SQ injec-
            tion tid, but its efficacy is currently unknown.  Prognosis
          ● Medical management together with intermittent
                                                        The success of medical management has been docu-
            thoracocentesis may be used during the treatment
                                                        mented at 20% or less. The author’s clinical experience
            for the underlying disease (cardiac therapy, cancer
                                                        has been somewhat below that figure. Traumatic injuries
            treatments, etc.).
                                                        to the thoracic duct may have a slightly better response
          Surgical management.                          rate to medical management. Successful treatment of the
          ● Surgery should only be considered for patients who  underlying disease process usually results in resolution
            do not respond to medical management within 6–10  of the chylothorax for taurine-responsive dilated car-
            days. Success following surgery is disappointingly  diomyopathy and neoplasia. The poor success rate in
            low. Surgery is best performed by a specialist with  idiopathic chylothorax likely relates to persistence of the
            experience in thoracic duct ligation.       underlying pathophysiology.
            – Ligation of the thoracic duct is the definitive
                                                        Prognosis for success of surgical ligation varies from
               therapy for idiopathic chylothorax. Surgical
                                                        25–53%, and likely varies directly with the skill and
               approaches and techniques are described in
                                                        experience of the surgeon. Continued effusion occurred
               standard surgical texts. Some surgeons prefer
                                                        in 30% of cats after thoracic duct ligation in one study.
               to give cream orally prior to surgery so that
                                                        Proponents of the primary lymphatic hypertension the-
               the thoracic duct is filled with white chyle at
                                                        ory feel that surgical ligation does not change the under-
               the time of surgery, for easier identification.
                                                        lying pathophysiology. New data regarding the success
               Others prefer to perform a mesenteric lym-
                                                        rate of pericardectomy are very promising, with one
               phatic dye study similar to what is described
                                                        report of an 80% remission rate in ten cats.
               for lymphangiography, but using new methyl-
               ene blue dye rather than radiographic contrast  Chyle is a very irritating fluid to the pleura. Chylofibrosis
               material. This dye is visible at the time of sur-  and restrictive pleuritis may follow as a complication
               gery to ease identification.             even after successful surgical ligation. If the fibrosis is
            – A postoperative contrast lymphangiogram may be  severe, the lungs may fail to expand even after thoraco-
               performed through the same mesenteric lymphatic  centesis. Pleural stripping has been described, but is not
               catheter to assess the success of the ligation.  commonly performed in cats, so the success rate is
               A thoracostomy tube is placed postoperatively  unknown.
   83   84   85   86   87   88   89   90   91   92   93